These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 19241604
1. Expression of VEGF, iNOS, and eNOS is increased in cochlea of diabetic rat. Liu F, Xia M, Xu A. Acta Otolaryngol; 2008 Nov; 128(11):1178-86. PubMed ID: 19241604 [Abstract] [Full Text] [Related]
2. Vascular endothelial growth factor in diabetes induced early retinal abnormalities. Cukiernik M, Hileeto D, Evans T, Mukherjee S, Downey D, Chakrabarti S. Diabetes Res Clin Pract; 2004 Sep; 65(3):197-208. PubMed ID: 15331199 [Abstract] [Full Text] [Related]
3. Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity. Kaur C, Sivakumar V, Ang LS, Sundaresan A. J Neurochem; 2006 Aug; 98(4):1200-16. PubMed ID: 16787408 [Abstract] [Full Text] [Related]
4. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats. Nagareddy PR, Xia Z, MacLeod KM, McNeill JH. J Cardiovasc Pharmacol; 2006 Apr; 47(4):513-20. PubMed ID: 16680064 [Abstract] [Full Text] [Related]
5. Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats. Takeda M, Mori F, Yoshida A, Takamiya A, Nakagomi S, Sato E, Kiyama H. Diabetologia; 2001 Aug; 44(8):1043-50. PubMed ID: 11484083 [Abstract] [Full Text] [Related]
6. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation. Pala L, Cresci B, Manuelli C, Maggi E, Yamaguchi YF, Cappugi P, Rotella CM, Giannini S. Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941 [Abstract] [Full Text] [Related]
7. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats. Gao L, Yu DM. Chin Med J (Engl); 2008 Nov 05; 121(21):2129-33. PubMed ID: 19080171 [Abstract] [Full Text] [Related]
8. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats. Nagareddy PR, McNeill JH, MacLeod KM. Eur J Pharmacol; 2009 Jun 02; 611(1-3):53-9. PubMed ID: 19344709 [Abstract] [Full Text] [Related]
9. Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts. Jesmin S, Zaedi S, Shimojo N, Iemitsu M, Masuzawa K, Yamaguchi N, Mowa CN, Maeda S, Hattori Y, Miyauchi T. Am J Physiol Endocrinol Metab; 2007 Apr 02; 292(4):E1030-40. PubMed ID: 17148754 [Abstract] [Full Text] [Related]
10. Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats. Bojunga J, Dresar-Mayert B, Usadel KH, Kusterer K, Zeuzem S. Biochem Biophys Res Commun; 2004 Apr 09; 316(3):771-80. PubMed ID: 15033467 [Abstract] [Full Text] [Related]
11. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats. Jesmin S, Zaedi S, Maeda S, Yamaguchi I, Goto K, Miyauchi T. Exp Biol Med (Maywood); 2006 Jun 09; 231(6):925-31. PubMed ID: 16741025 [Abstract] [Full Text] [Related]
12. mRNA expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and vascular endothelial growth factor in esophageal mucosa biopsy specimens from patients with reflux esophagitis. Inamori M, Shimamura T, Nagase H, Abe Y, Umezawa T, Nakajima A, Saito T, Ueno N, Tanaka K, Sekihara H, Togawa J, Kaifu H, Tsuboi H, Kayama H, Tominaga S. Hepatogastroenterology; 2006 Jun 09; 53(69):361-5. PubMed ID: 16795973 [Abstract] [Full Text] [Related]
13. Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats. Nakamaki S, Satoh H, Kudoh A, Hayashi Y, Hirai H, Watanabe T. Exp Biol Med (Maywood); 2011 May 01; 236(5):614-20. PubMed ID: 21521713 [Abstract] [Full Text] [Related]
14. Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts. Felaco M, Grilli A, De Lutiis MA, Patruno A, Libertini N, Taccardi AA, Di Napoli P, Di Giulio C, Barbacane R, Conti P. Ann Clin Lab Sci; 2001 Apr 01; 31(2):179-86. PubMed ID: 11337908 [Abstract] [Full Text] [Related]
15. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats. Malyshev E, Tazi KA, Moreau R, Lebrec D. J Gastroenterol Hepatol; 2007 Dec 01; 22(12):2195-201. PubMed ID: 18031380 [Abstract] [Full Text] [Related]
17. Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney. Komers R, Schutzer WE, Reed JF, Lindsley JN, Oyama TT, Buck DC, Mader SL, Anderson S. Diabetes; 2006 Jun 01; 55(6):1651-9. PubMed ID: 16731827 [Abstract] [Full Text] [Related]
18. Nitric oxide synthases II and III and vascular endothelial growth factor are up-regulated in sciatic nerve after spiral cuff electrode implantation. Thil MA, Vince V, Veraart C, Delbeke J, Colin IM. J Neuroimmunol; 2005 Sep 01; 166(1-2):158-66. PubMed ID: 16038988 [Abstract] [Full Text] [Related]
19. Effects of a cGMP-specific phosphodiesterase inhibitor on expression of endothelial nitric oxide synthase and vascular endothelial growth factor in rats with cyclosporine-induced nephrotoxicity. Yang JW, Han ST, Kim YS, Song SH, Kim BR, Eom MS, Jung SH, Choi SO, Han BG. Transplant Proc; 2010 Dec 01; 42(10):4625-32. PubMed ID: 21168749 [Abstract] [Full Text] [Related]
20. Protective effects of a coumarin derivative in diabetic rats. Bucolo C, Ward KW, Mazzon E, Cuzzocrea S, Drago F. Invest Ophthalmol Vis Sci; 2009 Aug 01; 50(8):3846-52. PubMed ID: 19279317 [Abstract] [Full Text] [Related] Page: [Next] [New Search]